126 related articles for article (PubMed ID: 37026909)
1. Association of osteoporosis risk and polymorphisms of osteoprotegerin gene T950C in postmenopausal Chinese women: A PRISMA-compliant meta-analysis.
Xia Y; Chen H
Medicine (Baltimore); 2023 Apr; 102(14):e33511. PubMed ID: 37026909
[TBL] [Abstract][Full Text] [Related]
2. Association between osteoprotegerin gene T950C polymorphism and osteoporosis risk in the Chinese population: Evidence via meta-analysis.
Li S; Jiang H; Du N
PLoS One; 2017; 12(12):e0189825. PubMed ID: 29253005
[TBL] [Abstract][Full Text] [Related]
3. The genetic association between osteoprotegerin (OPG) gene polymorphisms and bone mineral density (BMD) in postmenopausal women: A meta-analysis.
Peng Y; Sheng X; Xue F; Qian Y
Medicine (Baltimore); 2018 Dec; 97(51):e13507. PubMed ID: 30572450
[TBL] [Abstract][Full Text] [Related]
4. [Polymorphisms of T149C and T950C genes in osteoprotegerin promoter sites and the relationship between serum osteoprotegerin levels and coronary heart disease].
Zhao F; Zhao H; Zhang R; Ren M; Liu C; Liu S; Ma J; Song Y; Liu T; Zhang X; Cong H
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Mar; 31(3):319-324. PubMed ID: 30914093
[TBL] [Abstract][Full Text] [Related]
5. Significant associations between the A163G and G1181C polymorphisms of the osteoprotegerin gene and risk of osteoporosis, especially in postmenopausal women: a meta-analysis.
Luo Y; Hu Z; Hao J; Jiang W; Shen J; Zhao J
Genet Test Mol Biomarkers; 2014 Mar; 18(3):211-9. PubMed ID: 24410296
[TBL] [Abstract][Full Text] [Related]
6. The association of OPG polymorphisms with risk of osteoporotic fractures: A systematic review and meta-analysis.
Ding J; Zhang C; Guo Y
Medicine (Baltimore); 2021 Aug; 100(31):e26716. PubMed ID: 34397809
[TBL] [Abstract][Full Text] [Related]
7. Association of VDR and OPG gene polymorphism with osteoporosis risk in Chinese postmenopausal women.
Wu F; Zhou D; Shen G; Cui Y; Lv Q; Wei F
Climacteric; 2019 Apr; 22(2):208-212. PubMed ID: 30624097
[TBL] [Abstract][Full Text] [Related]
8. Association between seven common OPG genetic polymorphisms and osteoporosis risk: a meta-analysis.
Guo L; Tang K; Quan Z; Zhao Z; Jiang D
DNA Cell Biol; 2014 Jan; 33(1):29-39. PubMed ID: 24283361
[TBL] [Abstract][Full Text] [Related]
9. Association analyses of osteoprotegerin gene polymorphisms with bone mineral density in Chinese postmenopausal women.
Zhang F; He C; Chen G; Li F; Gao H
Med Oncol; 2013 Mar; 30(1):389. PubMed ID: 23335067
[TBL] [Abstract][Full Text] [Related]
10. Association between
Han X; Zheng L; Mu YY; Li HZ; He XF
Front Genet; 2022; 13():1032110. PubMed ID: 36437941
[No Abstract] [Full Text] [Related]
11. Common Variants of the
Li X; Cheng J; Dong B; Yu X; Zhao X; Zhou Z
Genet Test Mol Biomarkers; 2021 Sep; 25(9):600-610. PubMed ID: 34515523
[No Abstract] [Full Text] [Related]
12. Polymorphisms of OPG and their relation to the mineral density of bones in pre- and postmenopausal women.
Boroń D; Kotrych D; Bartkowiak-Wieczorek J; Uzar I; Bogacz A; Kamiński A
Int Immunopharmacol; 2015 Sep; 28(1):477-86. PubMed ID: 26202809
[TBL] [Abstract][Full Text] [Related]
13. The influence of osteoprotegerin genetic polymorphisms on bone mineral density and osteoporosis in Chinese postmenopausal women.
Sun T; Chen M; Lin X; Yu R; Zhao Y; Wang J
Int Immunopharmacol; 2014 Sep; 22(1):200-3. PubMed ID: 24975835
[TBL] [Abstract][Full Text] [Related]
14. Associations between WNT signaling pathway-related gene polymorphisms and risks of osteoporosis development in Chinese postmenopausal women: a case-control study.
Yang Z; Liu J; Fu J; Li S; Chai Z; Sun Y
Climacteric; 2022 Jun; 25(3):257-263. PubMed ID: 34254535
[TBL] [Abstract][Full Text] [Related]
15. Association between IGF-1 polymorphisms and risk of osteoporosis in Chinese population: a meta-analysis.
Gao ST; Lv ZT; Zhou CK; Mao C; Sheng WB
BMC Musculoskelet Disord; 2018 May; 19(1):141. PubMed ID: 29747606
[TBL] [Abstract][Full Text] [Related]
16. Single-nucleotide polymorphism of the osteoprotegerin gene and its association with bone mineral density in Chinese postmenopausal women.
Feng G; Meng L; Wang H; Lu Y; Jia J; Zhang Y; Zhang H; Zhang B
J Pediatr Endocrinol Metab; 2012; 25(11-12):1141-4. PubMed ID: 23329761
[TBL] [Abstract][Full Text] [Related]
17. Integrative Analysis Confirmed the Association between Osteoprotegerin and Osteoporosis.
Tang H; Zhu XW; Wu LF; Mo XB; Deng FY; Lei SF
Chin Med Sci J; 2019 Jun; 34(2):147-156. PubMed ID: 31315756
[TBL] [Abstract][Full Text] [Related]
18. Osteoprotegerin SNP associations with coronary artery disease and ischemic stroke risk: a meta-analysis.
Wu J; Li X; Gao F; Gao S; Lyu J; Qiang H
Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 32955093
[TBL] [Abstract][Full Text] [Related]
19. The relationship between osteoprotegerin gene polymorphisms and bone mineral density in Chinese postmenopausal women.
Wang Q; Chen Z; Huang Y; Li Q; Zhu L; Cai X; He G; Xie Y; Liu Q
Int Immunopharmacol; 2013 Oct; 17(2):404-7. PubMed ID: 23856613
[TBL] [Abstract][Full Text] [Related]
20. [Osteoprotegerin gene polymorphism and therapeutic response to alendronate in postmenopausal women with osteoporosis].
Wang C; He JW; Qin YJ; Zhang H; Hu WW; Liu YJ; Zhang ZL
Zhonghua Yi Xue Za Zhi; 2009 Nov; 89(42):2958-62. PubMed ID: 20137703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
